Literature DB >> 26813732

Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study.

Philippe Généreux1,2,3, Björn Redfors1,4, Bernhard Witzenbichler5, Akiko Maehara1,2, Mayank Yadav1, Giora Weisz1,2,6, Dominic P Francese1, Rupa Parvataneni1, Sorin J Brener7, Roxana Mehran1,8, Ajay J Kirtane1,2, Gregg W Stone1,2.   

Abstract

OBJECTIVES: We sought to identify angiographic predictors of 2-year stent thrombosis (ST) in the ADAPT-DES study.
BACKGROUND: A strong relationship between platelet reactivity and ST after implantation of drug-eluting stents (DES) was recently confirmed in the prospective, multicenter ADAPT-DES study.
METHODS: In a pre-specified analysis of patients enrolled in ADAPT-DES, an independent angiographic core laboratory performed detailed angiographic analyses for all cases of ST. Patients with Academic Research Consortium definite/probable target-lesion ST were matched with controls in a 1:2 ratio, and multivariable Cox regression models identified angiographic predictors of 2-year ST.
RESULTS: Among 8,582 patients who had successful percutaneous coronary intervention (PCI) and were included in the ADAPT-DES study, 92 (1.1%) patients had ST at 2-year follow-up. Target lesion-related ST was identified in 77 patients (82 lesions) who were clinically matched with 153 patients (196 lesions) without ST. Patients with ST were more likely to have longer target lesions, thrombus, moderate/severe calcification, American College of Cardiology/American Heart Association (ACC/AHA) type C lesions, and saphenous vein grafts. After adjustment for clinical covariates the angiographic variables that predicted ST were lesion complexity (ACC/AHA type C lesion, adjusted HR: 1.97, 95% CI: 1.19 to 3.26, P = 0.01) and presence of thrombus on index PCI (HR: 2.25, 95% CI: 1.40 to 3.59, P < 0.01).
CONCLUSIONS: Anatomically complex lesions and the presence of thrombus are strong predictors of 2-year ST in the DES era.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  drug-eluting stent; percutaneous coronary intervention; stent thrombosis

Mesh:

Substances:

Year:  2016        PMID: 26813732     DOI: 10.1002/ccd.26409

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Predictors and Long-Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Intravascular Ultrasound Substudy.

Authors:  Bin Wang; Gary S Mintz; Bernhard Witzenbichler; Cristiano F Souza; D Christopher Metzger; Michael J Rinaldi; Peter L Duffy; Giora Weisz; Thomas D Stuckey; Bruce R Brodie; Mitsuaki Matsumura; Myong-Hwa Yamamoto; Rupa Parvataneni; Ajay J Kirtane; Gregg W Stone; Akiko Maehara
Journal:  J Am Heart Assoc       Date:  2016-12-22       Impact factor: 5.501

2.  Five-year clinical follow-up of the STENTYS self-apposing stent in complex coronary anatomy: a single-centre experience with report of specific angiographic indications.

Authors:  H Lu; R J Bekker; M J Grundeken; P Woudstra; J J Wykrzykowska; J G P Tijssen; R J de Winter; K T Koch
Journal:  Neth Heart J       Date:  2018-05       Impact factor: 2.380

3.  Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trial.

Authors:  Rosaly A Buiten; Eline H Ploumen; Paolo Zocca; Carine J M Doggen; K Gert van Houwelingen; Peter W Danse; Carl E Schotborgh; Martin G Stoel; Martijn Scholte; Gerard C M Linssen; Frits H A F de Man; Clemens von Birgelen
Journal:  Catheter Cardiovasc Interv       Date:  2020-04-01       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.